Neumora Therapeutics (NASDAQ:NMRA) Earns “Buy” Rating from HC Wainwright
HC Wainwright restated their buy rating on shares of Neumora Therapeutics (NASDAQ:NMRA – Free Report) in a research report released on Friday,Benzinga reports. They currently have a $30.00 price objective on the stock. Other equities analysts have also issued reports about the company. Bank of America dropped their price objective on Neumora Therapeutics from $22.00 […]
HC Wainwright restated their buy rating on shares of Neumora Therapeutics (NASDAQ:NMRA – Free Report) in a research report released on Friday,Benzinga reports. They currently have a $30.00 price objective on the stock. Other equities analysts have also issued reports about the company. Bank of America dropped their price objective on Neumora Therapeutics from $22.00 […]
